CRISPR Therapeutics also has a therapy for Beta Thalassemia in human trials that is up for approval in February 2024. “Editing Humanity” by Kevin Davies covers

CRISPR Therapeutics also has a therapy for Beta Thalassemia in human trials that is up for approval in February 2024. “Editing Humanity” by Kevin Davies covers the history and near future of CRISPR and includes a great chapter on describing both of these therapies.